Home

  • Order to parcel locker

    Order to parcel locker

  • easy pay

    easy pay
  • Reduced price
50 Studies Every Ophthalmologist Should Know

50 Studies Every Ophthalmologist Should Know

9780190050726
365.04 zł
328.54 zł Save 36.50 zł Tax included
Lowest price within 30 days before promotion: 328.54 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
50 Studies Every Ophthalmologist Should Know presents key studies that have shaped the practice of ophthalmology. Selected using a rigorous methodology, emphasis has been placed on landmark studies which have influenced current ophthalmology practice guidelines. For each study, a concise summary is presented with an emphasis on the results and limitations of the study, and its implications for practice. An illustrative clinical case concludes each review, followed by briefinformation on other relevant studies. This book is a must-read for ophthalmologists, especially those in training or preparing for board review, as well as anyone who wants to learn more about the data behind clinical practice.
Product Details
OUP USA
88878
9780190050726
9780190050726

Data sheet

Publication date
2020
Issue number
1
Cover
paperback
Pages count
336
Dimensions (mm)
156 x 235
Weight (g)
567
  • 1. Effectiveness of Histocompatibility Matching in High-Risk Corneal Transplantation; 2. Topical Corticosteroids for Herpes Simplex Stromal Keratitis; 3. Topical Corticosteroids for Bacterial Keratitis; 4. Topical Natamycin versus Voriconazole for Fungal Corneal Ulcer; 5. Prevalence of Age-Related Lens Opacities in a Population; 6. Risk Factors for Cataract; 7. High-Dose Supplementation with Vitamins C and E and Beta Carotene for Age-Related Cataract and Vision Loss; 8. Routine Preoperative Medical Testing Before Cataract Surgery.; 9. Prophylaxis of Postoperative Endophthalmitis Following Cataract Surgery; 10. The Relationship Between Optic Disc Area and Open-Angle Glaucoma; 11. Is argon laser trabeculoplasty equivalent to topical medication as an initial treatment for primary open-angle glaucoma?; 12. Intraocular Pressure Reduction in the Treatment of Normal-Tension Glaucoma; 13. The Relationship Between Control of Intraocular Pressure after Surgical Intervention for Glaucoma and Visual Field Deterioration; 14. Reduction of intraocular pressure and glaucoma progression; 15. Topical ocular hypotensive medication to delay or prevent the onset of primary open-angle glaucoma; 16. Intraocular Pressure Control and Long-Term Visual Field Loss in Open-Angle Glaucoma; 17. Latanoprost for Open-Angle Glaucoma; 18. Tube Shunt Surgery Versus Trabeculectomy in Eyes with Prior Ocular Surgery and Uncontrolled Glaucoma; 19. Pooled Data Analysis of the Ahmed Baerveldt Comparison Study and the Ahmed Versus Baerveldt Study; 20. Risk Factors for Branch and Central Retinal Vein Occlusion; 21. Argon Laser Photocoagulation for Macular Edema in Branch Vein Occlusion; 22. Intraocular Injections of Ranibizumab in Patients With Macular Edema Following Branch Retinal Vein Occlusion; 23. Grid Pattern Photocoagulation for Macular Edema in Central Vein Occlusion; 24. Steroids in the Treatment of Central Retinal Vein Occlusion; 25. Cryotherapy for Retinopathy of Prematurity; 26. Supplemental Therapeutic Oxygen for Pre-Threshold Retinopathy of Prematurity; 27. Early Treatment of Prethreshold Retinopathy of Prematurity; 28. Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity; 29. Photocoagulation for Diabetic Macular Edema; 30. Early Photocoagulation for Diabetic Retinopathy; 31. Does Pars Plana Vitrectomy Improve Visual Outcomes in Patients with Complications of Proliferative Diabetic Retinopathy; 32. Intensive Diabetes Management to Reduce the Risk of Retinopathy Developing or Progressing; 33. Progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus; 34. Immediate Vitrectomy and Intravenous Antibiotics for the Treatment of Postoperative Bacterial Endophthalmitis; 35. Prevalence of Age-Related Maculopathy; 36. Does high-dose supplementation with vitamins C and E, beta carotene, and zinc slow the progression of age-related macular degeneration and vision loss?; 37. Argon laser photocoagulation for extrafoveal neovascular maculopathy; 38. Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration with Verteporfin; 39. Pegaptanib for Neovascular Age-Related Macular Degeneration; 40. Ranibizumab for Neovascular Age-Related Macular Degeneration; 41. Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration; 42. Effect of Pre-Enucleation Radiation on Mortality in Large Choroidal Melanomas; 43. Systemic Anti-Inflammatory Therapy versus Fluocinolone Acetonide; 44. Botulinum A Toxin Injection into Extraocular Muscles as an Alternative to Strabismus Surgery; 45. Botulinum A Toxin Injection as a Treatment for Blepharospasm; 46. A Clinical Activity Score That Discriminates Between Inflammatory and Non-Inflammatory Graves Ophthalmopathy; 47. Corticosteroids in the Treatment of Acute Optic Neuritis; 48. Atropine or Patching for Treatment of Moderate Amblyopia in Children; 49. Contact Lens vs Intraocular Lens Correction of Monocular Aphakia During Infancy; 50. Effect of Acetazolamide on Visual Function in Patients With Idiopathic Intracranial Hypertension and Mild Visual Loss;
Comments (0)

  • Frequently purchased together

    No products available